RxDoctor Payments Data

William McClung, APRN

Family · Panama City Beach, FLNPI 1356664817

Payments from drug & device makers

$4,578in general payments, 2019–2025

Across 279 payments — averaging $16.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$987
  • Novo Nordisk$733
  • AstraZeneca$666
  • Lilly USA, LLC$539
  • Amgen$408
  • Pfizer$336
  • plus $910 from 15 others

What the payments were for

  • Food & beverage$4,578100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,578 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$3,894
Medicare patients
30
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide21$38,088
FarxigaDapagliflozin Propanediol23$35,680
EntrestoSacubitril/Valsartan29$29,084
EliquisApixaban25$26,825
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,692
Janumet XrSitagliptin Phos/Metformin Hcl13$7,960
Omeprazole186$3,141
Gabapentin128$2,684
Atorvastatin Calcium249$2,505
Levothyroxine Sodium141$2,253
Duloxetine Hcl17$1,851
Albuterol Sulfate HfaAlbuterol Sulfate45$1,634
Lisinopril194$1,581
Ezetimibe44$1,359
Montelukast Sodium118$1,348

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$733$38,08821 claims
AstraZenecaFarxiga$666$35,68023 claims
NovartisEntresto$104$29,08429 claims
PfizerEliquis$336$26,82525 claims
GSKTrelegy Ellipta$135$8,69213 claims
MerckJanumet Xr$18$7,96013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 14,618 family providers in Florida.

Other family in Panama City Beach

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →